Prope tolerance: The future of organ transplantation - From the laboratory to the clinic

被引:38
作者
Calne, RY [1 ]
机构
[1] Dept Surg, Cambridge CB2 2AH, England
关键词
D O I
10.1097/01.TP.0000117776.14277.03
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This is a short review of tolerance from the point of view of the clinician. Various examples of tolerance occurring in patients and animal models that relate to the clinical experience are described. There may be different mechanisms by which tolerance is achieved, but from the patient's point of view operational tolerance is the goal whereby, after a short induction procedure, the patient will maintain good function in the grafted organ indefinitely without maintenance immunosuppression. Such a goal may be difficult to achieve with any given protocol because of the enormous variation between donors and recipients of organ grafts in tissue matching, innate immune reactivity, and susceptibility to disturbance of a tolerant state by infections or allergic reactions. Thus the case is made for prope or "almost" tolerance in which graft acceptance is maintained by a low, nontoxic dosage of maintenance immunosuppression that may not be required indefinitely.
引用
收藏
页码:930 / 932
页数:3
相关论文
共 33 条
[11]  
CALNE RY, 1961, TRANSPLAN B, V28, P445
[12]   AZATHIOPRINE WITHDRAWAL IN RENAL-TRANSPLANT RECIPIENTS - A LONG-TERM FOLLOW-UP [J].
CAMPOS, H ;
KREIS, HA ;
RIOUX, P ;
CROSNIER, J .
TRANSPLANTATION, 1984, 38 (01) :29-31
[13]  
Cecka J M, 1997, Clin Transpl, P1
[14]   Stable α- and β-islet cell function after tolerance induction to pancreatic islet allografts in diabetic primates [J].
Contreras, JL ;
Jenkins, S ;
Eckhoff, DE ;
Hubbard, WJ ;
Lobashevsky, A ;
Bilbao, G ;
Thomas, FT ;
Neville, DM ;
Thomas, JM .
AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (02) :128-138
[15]  
FRIEND PJ, 1995, TRANSPLANT P, V27, P869
[16]  
Gibson T, 1943, J ANAT, V77, P299
[17]  
HALE G, 1988, LANCET, V2, P1394
[18]  
HELG C, 1994, TRANSPLANTATION, V58, P1420
[19]   TOLERANCE TO AN HLA-B,DR DISPARATE KIDNEY ALLOGRAFT AFTER BONE-MARROW TRANSPLANTATION FROM SAME DONOR [J].
JACOBSEN, N ;
TAANING, E ;
LADEFOGED, J ;
KRISTENSEN, JK ;
PEDERSEN, FK .
LANCET, 1994, 343 (8900) :800-800
[20]   CTLA4-Ig and anti-CD4O ligand prevent renal allograft rejection in primates [J].
Kirk, AD ;
Harlan, DM ;
Armstrong, NN ;
Davis, TA ;
Dong, YC ;
Gray, GS ;
Hong, XN ;
Thomas, D ;
Fechner, JH ;
Knechtle, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (16) :8789-8794